US Patent

US10987364 — Synthetic progestogens and pharmaceutical compositions comprising the same

Formulation · Assigned to Laboratorios Leon Farma SA · Expires 2031-06-28 · 5y remaining

Vulnerability score 56/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects synthetic progestogens, such as 6β,7β:15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone, and pharmaceutical compositions containing them.

USPTO Abstract

Described herein are synthetic progestogens, such as 6β,7β:15β,16β-Dimethylene-3-oxo-17α-pregn-4-ene-21,17-carbolactone, as well as pharmaceutical compositions comprising the same. Also described are methods of use.

Drugs covered by this patent

Patent Metadata

Patent number
US10987364
Jurisdiction
US
Classification
Formulation
Expires
2031-06-28
Drug substance claim
No
Drug product claim
Yes
Assignee
Laboratorios Leon Farma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.